Immunosuppression by delta opioid receptor antagonist
Arakawa, K.; Akami, T.; Okamoto, M.; Akioka, K.; Nakai, I.; Oka, T.; Nagase, H.
Transplantation Proceedings 25(1 Part 1): 738-740
1993
ISSN/ISBN: 0041-1345 PMID: 8382386 Document Number: 413442
Document emailed within 1 workday
Related Documents
Bot, G.; Blake, A.D.; Li, S.; Reisine, T. 1998: Mutagenesis of the mouse delta opioid receptor converts (-)-buprenorphine from a partial agonist to an antagonist Journal of Pharmacology and Experimental Therapeutics 284(1): 283-290Sofuoglu, M.; Portoghese, P.S.; Takemori, A.E. 1991: Differential antagonism of delta opioid agonists by naltrindole and its benzofuran analog (NTB) in mice: evidence for delta opioid receptor subtypes Journal of Pharmacology and Experimental Therapeutics 257(2): 676-680
Fang, L.; Knapp, R.J.; Horvath, R.; Matsunaga, T.O.; Haaseth, R.C.; Hruby, V.J.; Porreca, F.; Yamamura, H.I. 1994: Characterization of [3H]naltrindole binding to delta opioid receptors in mouse brain and mouse vas deferens: evidence for delta opioid receptor heterogeneity Journal of Pharmacology and Experimental Therapeutics 268(2): 836-846
Spetea, M.; Asim, M.Faheem.; Noha, S.; Wolber, G.; Schmidhammer, H. 2013: Current κ opioid receptor ligands and discovery of a new molecular scaffold as a κ opioid receptor antagonist using pharmacophore-based virtual screening Current Pharmaceutical Design 19(42): 7362-7372
Mosberg, H.I.; Heyl, D.L.; Haaseth, R.C.; Omnaas, J.R.; Medzihradsky, F.; Smith, C.B. 1990: Cyclic dermorphin-like tetrapeptides with delta-opioid receptor selectivity. 3. Effect of residue 3 modification on in vitro opioid activity Molecular Pharmacology 38(6): 924-928
Jiang, Q.; Takemori, A.E.; Sultana, M.; Portoghese, P.S.; Bowen, W.D.; Mosberg, H.I.; Porreca, F. 1991: Differential antagonism of opioid delta antinociception by [D-Ala2,Leu5,Cys6]enkephalin and naltrindole 5'-isothiocyanate: evidence for delta receptor subtypes Journal of Pharmacology and Experimental Therapeutics 257(3): 1069-1075
Schoffelmeer, A.N.; Yao, Y.H.; Gioannini, T.L.; Hiller, J.M.; Ofri, D.; Roques, B.P.; Simon, E.J. 1990: Cross-linking of human [125I]beta-endorphin to opioid receptors in rat striatal membranes: biochemical evidence for the existence of a mu/delta opioid receptor complex Journal of Pharmacology and Experimental Therapeutics 253(1): 419-426
Rónai, A.Z.; Botyánszki, J.; Magyar, A.; Borsodi, A.; Benyhe, S.; Medzihradszky, K. 1993: Novel, delta-opioid receptor-selective peptide antagonists: demonstration of a possible opioid interaction in the absence of a protonated nitrogen and attempts to locate the protonated nitrogen site Archives Internationales de Pharmacodynamie et de Therapie 323: 114-125
Portoghese, P.S. 1993: The design of delta-selective opioid receptor antagonists Farmaco 48(2): 243-251
Pei, G.; Kieffer, B.L.; Lefkowitz, R.J.; Freedman, N.J. 1995: Agonist-dependent phosphorylation of the mouse delta-opioid receptor: involvement of G protein-coupled receptor kinases but not protein kinase C Molecular Pharmacology 48(2): 173-177
Mayfield, K.P.; D'Alecy, L.G. 1994: Delta-1 opioid receptor dependence of acute hypoxic adaptation Journal of Pharmacology and Experimental Therapeutics 268(1): 74-77
Rong, S.B.; Jiang, H.L.; Chi, Z.Q.; Chen, K.X.; Zhu, Y.C.; Ji, R.Y. 1997: Molecular modeling of interaction between delta opioid receptor and 3-methylfentanylisothiocyanate Zhongguo Yao Li Xue Bao 18(3): 219-224
Schreiber, G.; Campa, M.J.; Prabhakar, S.; O'Briant, K.; Bepler, G.; Patz, E.F. 1998: Molecular characterization of the human delta opioid receptor in lung cancer Anticancer Research 18(3a): 1787-1792
Kato, H. 2008: Pharmacological effects of a mu-opioid receptor antagonist naltrexone on alcohol dependence Nihon Arukoru Yakubutsu Igakkai Zasshi 43(5): 697-704
Govitrapong, P.; Sawlom, S.; Chetsawang, B.; Sangchot, P.; Ebadi, M. 2002: The bovine pineal gland contains delta and mu but not kappa or ORL1 opioid receptor subtypes Proceedings of the Western Pharmacology Society 45: 32-35
Keys, C.; Payne, P.; Amsterdam, P.; Toll, L.; Loew, G. 1988: Conformational determinants of high affinity delta receptor binding of opioid peptides Molecular Pharmacology 33(5): 528-536
Fox-Threlkeld, J.E.; Daniel, E.E.; Christinck, F.; Hruby, V.J.; Cipris, S.; Woskowska, Z. 1994: Identification of mechanisms and sites of actions of mu and delta opioid receptor activation in the canine intestine Journal of Pharmacology and Experimental Therapeutics 268(2): 689-700
Charness, M.E.; Hu, G.; Edwards, R.H.; Querimit, L.A. 1993: Ethanol increases delta-opioid receptor gene expression in neuronal cell lines Molecular Pharmacology 44(6): 1119-1127
Tao, P.L.; Law, P.Y.; Loh, H.H. 1987: Decrease in delta and mu opioid receptor binding capacity in rat brain after chronic etorphine treatment Journal of Pharmacology and Experimental Therapeutics 240(3): 809-816
Freye, E.; Latasch, L.; Portoghese, P.S. 1992: The delta receptor is involved in sufentanil-induced respiratory depression--opioid subreceptors mediate different effects European Journal of Anaesthesiology 9(6): 457-462